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Abstract
Background: Vertigo and dizziness are symptoms which are reported frequently in clinical practice. We aimed to
develop diagnostic indices for four prevalent vertiginous diseases: benign paroxysmal positional vertigo (BPPV),
Menière’s disease (MD), vestibular migraine (VM), and phobic postural vertigo (PPV).
Methods: Based on a detailed questionnaire handed out to consecutive patients presenting for the first time in
our dizziness clinic we preselected a set of seven questions with desirable diagnostic properties when compared
with the final diagnosis after medical workup. Using exact logistic regression analysis diagnostic scores, each
comprising of four to six items that can simply be added up, were built for each of the four diagnoses.
Results: Of 193 patients 131 questionnaires were left after excluding those with missing consent or data. Applying
the suggested cut-off points, sensitivity and specificity were 87.5 and 93.5% for BPPV, 100 and 87.4% for MD, 92.3
and 83.7% for VM, 73.7 and 84.1% for PPV, respectively. By changing the cut-off points sensitivity and specificity
can be adjusted to meet diagnostic needs.
Conclusions: The diagnostic indices showed promising diagnostic properties. Once further validated, they could
provide an ease to use and yet flexible tool for screening vertigo in clinical practice and epidemiological research.
Background
Vertigo and dizziness are, like headache very prevalent
symptoms in daily clinical practice. The life time preva-
lence is estimated to be 20 - 30% [1]. For the symptom
headache it was shown that a very simple screener with
o n l yt h r e eq u e s t i o n sa r ea b l et o differentiate headaches
with a sensitivity of 0.81 (95% CI 0.77 to 0.85), a specifi-
city of 0.75 (95% CI 0.64 to 0.84), and a positive predic-
tive value of 0.93 (95% CI, 89.9 to 95.8) to predict a
migraine [2]. Therefore we investigated whether such a
screener which can be easily filled out by the patients
during the time in the waiting room can be also devel-
oped for patients suffering from vertigo or dizziness. We
focused our efforts on the differentiation of the most
prevalent diagnoses benign paroxysmal positional vertigo
(BPPV), Meniere’s disease (MD), vestibular migraine
(VM) and phobic postural vertigo (PPV) since these
four diagnoses cover about 54% of all patients in a dizzi-
ness out patient unit [1]. The screener was developed by
analysing a larger questionnaire, which was administered
to patients presenting in a dizziness clinic at the neurol-
ogy department of Munich university, a tertiary center
for vertigo disorders.
Methods
We conceived a short questionnaire by analysing and
subsequently condensing a detailed questionnaire
designed for patients suffering from vertiginous diseases.
The detailed questionnaire with specific questions about
vertiginous diseases evolved on the basis of the pain
questionnaire of the German Society for the Study of
Pain http://www.dgss.org, chapter of the IASP. Data col-
lection was done between 2003 and 2007. In order to
get detailed and structured information about the his-
tory of the patients and the signs of the actual clinical
symptoms we asked the patients to fill in the question-
naire. Since this data collection was introduced as a
pilot the questionnaire was handed out on predefined
dates (usually once a week) to all patients presenting for
the first time in the dizziness clinic on that day to
obtain an unbiased sample. All patients gave their writ-
ten informed consent to this procedure. Since the study
was not experimental, and the data were gained in clini-
cal routine, the approval of an ethics committee was not
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seen by two experienced neurologists who were blinded
to the answers given in the questionnaire and received a
complete medical work up with patients undergoing a
clinical neurological examination, orthoptic examination,
eye movement recording, and, if necessary, Doppler
sonography of the cranial vessels, evoked potentials, cra-
nial imaging and consultations of other specialities (e.g.
ENT, ophthalmology, and psychiatry). For further details
see [3]; the questions are listed in the additional file 1.
The analyses were based on clinical diagnoses rather
than on restrictive inclusion criteria, such as used e. g.
in clinical trials. Although the latter approach has the
advantage of high diagnostic accuracy, it restricts the
study sample to typical patients with clear syndromes,
which does not always match with clinical reality. Diag-
nostic criteria applied in the clinic were: for PPV as
described by Brandt [4]. BPPV was diagnosed if repro-
ducable by positioning maneuvers, or in case of a dis-
tinctive history with other causes ruled out. MD
according to the AAO-HNS [5,6] criteria, if hearing loss
was not audiologically documented before or in the
ENT department, anamnestic hearing loss was accepted.
VM patients fulfilled the criteria of definite or probable
migrainous vertigo [7].
We developed diagnostic indices for the four most fre-
quent diagnoses: PPV (n = 53), BPPV (n = 19), VM (n =
14) and MD (n = 11). First we screened the detailed
questionnaire for items potentially useful for diagnostic
indices:
◦ The kind of vertigo (rotational vertigo, unsteadiness,
feeling of being in a lift, lightheadedness)
◦ Perception of the environment (like on a round-
about, like on a boat, very blurred)
◦ The occurence of vertigo (in attacks, persistent, per-
sistent with attacks)
◦ Duration of attacks (seconds, minutes, hours, days,
more than one week)
◦ Intensity of vertigo attacks and intensity of persistent
vertigo (intensity scale from no vertigo “0” to the most
intense possible vertigo “10”)
◦ Trigger with pre-formulated answers: “alleviating”,
“no influence” or “ amplifying” (physical load, psycholo-
gical load, darkness or bad sight, turning while staying
in bed, head inclination, bending down, raise, relaxing
itself, shaking the head, cough, large heights)
◦ Concomitant symptoms with pre-formulated
answers: “always”, “frequently”, “occasionally”, “never”
(vision disorders, diplopic images, speech disorder or
dysphagia, paraesthesia, paralysis, sweating, drop seizure,
headache, defective hearing, ear noises, nausea, vomit-
ing, impaired consciousness)
After screening of the larger questionnaire the follow-
ing items were chosen for further investigation: The
kind of vertigo (rotational vertigo, unsteadiness, feeling
of being in a lift, lightheadedness), perception of the
environment (like on a roundabout, like on a boat, very
blurred), and the concomitant symptoms defective hear-
ing, ear noises, nausea, vomiting, sweating, drop seizures
with pre-formulated answers “always”, “frequently”,
“occasionally”, “never”.
Sensitivity, specificity, positive and negative predictive
value with respect to the four main diagnoses were cal-
culated for these questions (Table 1). Based on the posi-
tive likelihood ratio (i. e. sensitivity/(1 - specificity),
primary criterion) and the other test measures men-
tioned above, variables were built and preselected as
Table 1 Sensitivity and specificity of the items included
in the diagnostic indices
PPV BPPV MD VM
sens. spec. sens. spec. sens. spec. sens. spec.
occurrence of vertigo
in attacks 0.32 0.28 0.74 0.47 0.91 0.48 0.79 0.47
as persistent v~ 0.38 0.91 0.00 0.76 0.00 0.78 0.00 0.77
kind of vertigo
rotatory vertigo 0.21 0.25 0.79 0.62 0.64 0.57 0.79 0.60
unsteadiness 0.64 0.68 0.16 0.43 0.46 0.51 0.43 0.50
lift feeling 0.15 1.00 0.00 0.89 0.00 0.91 0.00 0.90
lightheadedness 0.40 0.79 0.11 0.64 0.09 0.66 0.43 0.71
perception of environment
like on a
roundabout
0.26 0.26 0.79 0.58 0.64 0.51 0.77 0.54
like on a boat 0.64 0.65 0.32 0.46 0.46 0.50 0.31 0.47
very blurred 0.21 0.98 0.00 0.85 0.00 0.87 0.08 0.88
ear noises
never -
occasionally
0.70 0.33 0.88 0.35 0.10 0.23 0.86 0.34
frequently -
always
0.30 0.68 0.12 0.66 0.90 0.75 0.14 0.62
defective hearing
never -
occasionally
0.89 0.30 0.94 0.23 0.10 0.11 0.86 0.21
frequently -
always
0.11 0.68 0.06 0.77 0.90 0.89 0.14 0.65
nausea/vomiting/sweating
never -
occasionally
0.65 0.59 0.78 0.52 0.20 0.41 0.07 0.38
frequent -
always
0.35 0.40 0.22 0.48 0.80 0.58 0.93 0.62
drop seizure
never -
occasionally
0.80 0.24 1.00 0.27 0.50 0.23 0.64 0.19
frequently -
always
0.20 0.76 0.00 0.73 0.50 0.82 0.36 0.81
Note that the cut-off points for the ordinal variables ear noises, defective
hearing, nausea/vomiting/sweating, and drop seizures were chosen arbitrarily
and do not necessarily match those of the diagnostic indices.
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build the diagnostic score multivariate logistic regression
modelling was applied using a backward elimination
strategy for variable selection. The full model included
all preselected variables. The effect estimates with the
highest p-values were identified and the corresponding
variables were removed successively until only effects
significantly differing from 0 with p < 0.20 were left in
the model. The linear predictor of the resulting final
model was used as the diagnostic score, and calculated
for each patient with sufficient data. Finally, receiver
operating characteristics (ROC) curves were drawn,
where the area under the curve (AUC) served as a mea-
sure of the diagnostic index’s test power. An AUC of 1
indicates a perfect test.
The whole selection and modeling procedure was
done separately for the four diagnoses. To address the
problem of collinearity in multivariate modelling, we
computed Spearman’s rank correlation coefficients
(Table S1 in additional file 1) supplemented by a priori
knowledge to identify prediction variables of similar
content (rho >= 0.5). Whenever two such variables (e.g.
rotational vertigo and like on a roundabout) appear in a
model, the effect estimates are likely to become insignif-
icant. In these situations we tried replacing the variables
by one indicating, if at least one of the underlying ques-
tions was answered positively; in case of the example
rotational vertigo or like on a roundabout. In cases of
doubt we favoured the model resulting in the better
AUC. A useful side effect is that this approach also
increases the proportion of evaluable scores in case of
incompletely filled in questionnaires.
Due to a limited number of cases for some diagnoses,
some cells in the contingency tables happened to be
empty (e. g. none of the MD patients indicated having
persistent vertigo). This causes the problem of quasi-
complete separation of the data, which corrupts the cor-
responding maximum likelihood estimates in the usual
logistic regression. This problem is commonly circum-
vented by excluding the respective variables. However,
when building diagnostic indices, such a procedure
could lead to the exclusion of variables with high sensi-
tivity or specificity. We therefore applied exact logistic
regression using Firth’s 2nd order bias correction [8-10],
a method, which is now available in major statistical
software packages, that has been demonstrated to give
proper results in the situation just described [11].
Results
Of 193 patients 131 (74 female and 57 male, mean age
54, ranging from 16 to 90 years) were included, while
the remaining 62 patients were excluded because of
missing data or missing consent for this observational
study.
Diagnostic index for PPV
After the selection process described in methods, the
calculation of the diagnostic score for PPV was reduced
to five items as detailed in Table 2. When a cut-off
point of 0.31 is used, this diagnostic index had a sensi-
tivity of 73.7% and a specificity of 84.1%. The ROC
curve in Figure 1 depicts other sensitivities/specificities
that can be obtained by using other cut-off points. If,
for example, a very high sensitivity of 0.97 is desired,
the specificity would be lowered to 1 - 0.48 = 0.52. The
area under the curve was 0.845.
Diagnostic index for BPPV
The diagnostic index for BPPV used two more items;
the AUC of the ROC was 0.943. Using -1.22 as the cut-
off point resulted in a sensitivity of 87.5%, specificity of
93.5% and a positive predictive value of 73.7% (Figure 1).
Diagnostic index for MD
The diagnosis of MD was predicted by vertigo appearing
in attacks, the kind of vertigo, the perception of the
environment as well as the concomitant symptoms ear
noises and nausea, sweating, vomiting. The odds of the
outcome MD were associated with an increasing fre-
quency of these vegetative symptoms in a quite loglinear
fashion. At a cut-off point of 6.70 a sensitivity of 100%
and a specificity of 87.4% were computed for this diag-
nostic index, while the AUC was 0.988 (Figure 1).
Diagnostic index for VM
The diagnostic index for VM contained persistent ver-
tigo, rotational vertigo or perception of the environment
like on a roundabout, defective hearing or ear noises,
and sweating/nausea/vomiting. Using a cut-off point of
2.81 resulted in a sensitivity of 92.3% and specificity of
83.7%, the AUC was 0.894 (Figure 1).
Discussion
The diagnostic indices were developed as an instrument
to preselect patients with vertiginous diseases using a
simple screener on the basis of self reporting. Such a
screener can never completely replace a medical consul-
tation and a clinical examination of the patient. This is
especially true for patients suffering from vertigo of
multiple causes, e. g. PPV following organic vestibular
disorders, or complicated BPPV. However, it can help to
save time by allowing the examination to focus directly
on the main symptoms. Furthermore, it may be a useful
tool in epidemiological studies.
In the progress of building the diagnostic indices we
noticed that in some cases characteristics individually
had a relatively low sensitivity and specificity but that
the sensitivity and specificity increased in combination
with other characteristics.
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As expected, the construction of the diagnostic index for
PPV turned out to be intricate, since the characteristics
hardly had a sufficient sensitivity and specificity. In
some cases an earlier specific vertigo disease (e.g. vestib-
ular neuritis) can form the base of PPV [12], so the
diagnostic index ought to include modified symptoms of
the initial organic vertigo disease with the aid of variable
combinations of characteristics.
BPPV
While the clinical diagnosis of BPPV is quite straight
forward, the symptoms of BPPV may be caused by
different vertiginous diseases. Vestibular migraine imi-
tates the symptoms of BPPV in some patients [13].
Furthermore, there seems to be a statistical connection
between BPPV, MD and VM, without sufficient knowl-
edge about the underlying pathophysiology [14]. Since
they are typical BPPV symptoms, rotational vertigo and
feeling “like on a roundabout” not surprisingly met the
preselection criteria described in methods. Both were
tested independently and combined as a composite vari-
able (rotational vertigo OR roundabout) to resolve
potential collinearity issues. Interestingly, including
unsteadiness - which is a negative predictor of BPPV as
c a nb es e e nf r o mt h en e g a t i v es i g ni nT a b l e2-t u r n e d
Table 2 Calculation of the diagnostic scores for PPV, BPPV, MD, and VM
Question - Item/answer PPV BPPV MD VM
How does your vertigo occur?
in attacks 0 3.77
as persistent vertigo 2.22 -2.35 -1.79
as persistent vertigo with attacks 1.65
What kind of your vertigo do you have?
rotational vertigo -1.48
1 1.55
1
unsteadiness -3.26
feeling of being in a lift 1.79 -3.06
lightheadedness -2.54
How do you perceive the environment during vertigo?
like on a roundabout -1.48
1 1.55
1
like on a boat
blurred -3.42 -3.74
How often do you have defective hearing?
never
occasionally -1.14
2
frequently -1.14
2
always -1.14
2
How often do you have ear noises?
never
occasionally -1.14
2
frequently -1.14
2
always -3.03 5.42 -1.14
2
How often do you have sweating/nausea/vomiting?
never 0 = 0 · 0.98
occasionally 0.98 = 1 · 0.98
frequently -1.21
1 1.95 = 2 · 0.98 2.82
always -1.21
1 2.93 = 3 · 0.98
How often do you have drop seizures?
never
occasionally
frequently 1.70 -2.95
2
always -2.95
2
For answers marked in the questionnaire, the corresponding numbers are added up. Items marked with the same superscript number within one diagnosis are
scored only once. E. g. the score for PPV of a patient reporting „rotational vertigo“ or „perception of the environment like on a roundabout“ (both marked by 1)
will be diminished by 1.48 no matter whether this patient reports both or only one of these two symptoms. Patients are allowed to check only one answer per
question, except for the 2nd and 3rd question.
Examples of calculated scores can be found in the Additional file 1.
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tional vertigo or feeling “like on a roundabout”.
Although the items used in our questionnaire were not
specifically designed for BPPV, the sensitivity (0.875)
and specificity (0.935) of the diagnostic index fit well
with another study which reported a sensitivity of 0.88
and a specificity of 0.92 for recurrent attacks that lasted
less than one minute and typical head movement that
activates vertigo [15]. This combination of characteris-
tics had a sensitivity of 0.38 in patients with BPPV in
our study, since the sensitivity for vertigo attacks that
lasted only seconds had a sensitivity of 0.38. Further-
more typical head movement as a trigger for vertigo had
an equal sensitivity in patients with BPPV, PPV, MD
and VM. The prevalence of rotational vertigo in BPPV
patients was very similar (0.86 compared to 0.79 in our
study).
MD
Amongst other variables, the initial prediction model for
MD contained the well-established triad rotational ver-
tigo (sensitivity 0.64), ear noises and defective hearing.
However, defective hearing was dropped during the
selection process and thus does not appear in the final
diagnostic index. Being aware of the triad, we tried a
composite variable (defective hearing OR ear noises).
However, omitting ear noises finally led to the better
model. In comparison, a structured questionnaire on
Figure 1 ROC curves of the diagnostic score for phobic postural vertigo (PPV), benign paroxysmal positional vertigo (BPPV), Menières
disease (MD), and vestibular migraine (VM). Abbreviations used in the figure: Sensitivity (Sens), Specificity (Spec), positive predictive value (PV
+), negative predictive value (PV-).
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MD prevalence of 5% revealed a sensitivity, specificity
and positive predictive value of 0.80, 0.97, and 0.57,
respectively[16].
VM
The combinations of symptoms appeared heteroge-
neous in patients with VM. Rotational vertigo had the
highest sensitivity (0.79) but showed the same sensitiv-
ity in patients with BPPV and MD. This was already
noticed in a former study [13]. According to the find-
ings of Neuhauser and colleagues, the typical duration
of attacks varies among patients and thus is not suffi-
ciently specific [7]. The concomitant symptoms sweat-
ing/nausea/vomiting, which can also be found in the
IHS criteria for migraine elevated the sensitivity and
specificity of the diagnostic index. VM has already
been characterized as “the chameleon of vertiginous
diseases” due to the extreme variations of symptoms
which may last from minutes to hours [17]. Neverthe-
less, the diagnostic index achieved a good sensitivity
and specificity. In the ID migraine validation study
among patients presenting for routine primary care
appointments and reporting headaches in the past
three months a subset of three questions was identified
that revealed a sensitivity, specificity, and positive pre-
dictive value of 0.81, 0.75, and 0.93, respectively [2].
The much higher positive predictive value can be
attributed to a higher prevalence of VM patients in
this setting.
There are only a small number of other studies which
have tried to establish a diagnostic questionnaire for
vertigo. Most other studies have focused on the impact
of vertigo on the quality of life or tried to estimate the
subjective severity of vertigo. As there are established
vertigo questionnaires designed for the purposes just
described, it may be effective to extract diagnostic infor-
mation from these tools. A study identified a subset of
i t e m sf r o mt h ed i z z i n e s sh a n dicap inventory (DHI) to
detect BPPV in 373 patients referred to a tertiary center
[18]. The resulting score was reported to have a maxi-
mum positive likelihood ratio of 2.29 as compared to
13.5 in the present study.
A study about the role of open-ended questionnaires
conducted in 54 patients [19] suffering from vertigo,
supported our methods: When questions had a number
o fp o s s i b l ea n s w e r s ,p a t i e n t sw e r em o r el i k e l yt or e p o r t
their symptoms in full.
Another study in 57 patients used a matrix classifica-
tion based on type, episodic vs. persistent vertigo, and
hearing loss to assign one of the diagnoses BPPV, MD,
vestibular neuritis or labyrinthitis [20]. By comparison,
the sensitivity and specificity of this tool were 0.50, 0.89
for BPPV, and 0.73, 0.81 for MD, respectively.
It should be noted, that we did not confine the
patients to those given one of the four diagnoses investi-
gated; 26% had other diagnoses. This reflects the clinical
situation, where a patient complaining of vertigo is pre-
sented to the doctor, rather than a patient which is a
priori known to have either PPV, BPPV, MD, or VM
with the doctor only having to pick one out four possi-
ble diagnoses.
62 (32%) of the patients eligible could not be included
in the analysis, most of them because of not returning
the questionnaire. Keeping in mind, that the original
questionnaire where the items for the diagnostic indices
were embedded was 16 pages long, it is very likely to
obtain better participation in future studies by shorten-
ing the questionnaire. A summary of the patients
excluded has been published before ([3]http://www.bio-
medcentral.com/1471-2377/9/29, Table five). An overre-
presentation of one of the four diagnoses of interest
among these patients could give rise to concern that the
questionnaire is not suitable to a specific group of
patients. Compared to the patients included (PPV 53
(40.5%), BPPV 19 (14.5%), MD 11 (8.4%), VM 14
(10.7%)) such overrepresentation was not found, except
for MD (12.9 vs. 8.4%, p = 0.43).
The limitations of our study include the small number
of patients with MD (n = 11) and VM (n = 14), and the
findings should therefore be considered preliminary. A
test with a larger number of patients could help to
prove whether the sensitivity and specificity of the
screener hold. The diagnostic index was developed in
patients referred to our outpatient clinic, which is a ter-
tiary center for patients with vertigo and dizziness. In
the majority of cases these patients suffer from chronic
vertigo and were referred to our outpatient clinic after
several consultations with medical specialists. This prob-
ably results in an overrepresentation of patients who
were less easy to diagnose. The calculated sensitivity
and specificity values may therefore be even better in
unselected patients e. g. in a general practitioner’s
practice.
The advantage of our diagnostic indices is the devel-
opment of one screening questionnaire with identical
questions for four vertiginous diseases.
Conclusions
We proposed a short screener, from which diagnostic
scores for four prevalent vertiginous diseases can easily
be calculated. Although cut-off points were provided the
clinician or researcher may vary them to achieve better
sensitivity or specificity as needed in the particular set-
ting. The scores can also easily be converted to odds
ratios (OR = e
score) if desired. The test properties are
promising and further validation in other populations is
warranted.
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Additional file 1: containing supplementary tables, examples of
how to calculate the diagnostic scores, and the questionnaires
used.
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